Mortality and Other Important Diabetes-Related Outcomes With Insulin vs Other Antihyperglycemic Therapies in Type 2 Diabetes-Reference-Cited by-同舟云学术

Mortality and Other Important Diabetes-Related Outcomes With Insulin vs Other Antihyperglycemic Therapies in Type 2 Diabetes

Published:2013-02-01 Issue:2 Volume:98 Page:668-677
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Currie Craig J.¹²,Poole Chris D.¹²,Evans Marc³,Peters John R.³,Morgan Christopher Ll.¹²

Affiliation:

1. Department of Primary Care and Public Health (C.J.C., C.D.P., C.Ll.M.), School of Medicine, Cardiff University

2. Department of Global Epidemiology (C.J.C., C.D.P., C.Ll.M.), Pharmatelligence, Cardiff CF14 4UJ, United Kingdom

3. Department of Medicine (M.E., J.R.P.), University Hospital of Wales, Cardiff CF14 4XW, United Kingdom

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/98/2/668/20288379/jcem0668.pdf

Reference38 articles.

1. National Institute for Clinical Excellence. Type 2 diabetes: the management of type 2 diabetes. 2008. http://guidance.nice.org.uk/CG66. Accessed August 8, 2012.

2. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies;Emerging Risk Factors Collaboration;Lancet,2010

3. Intensified glucose lowering in type 2 diabetes: time for a reappraisal;Yudkin;Diabetologia,2010

4. European Medicines Agency. 2010 European Medicines Agency update on ongoing benefit-risk review of Avandia, Avandamet and Avaglim. http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2010/07/WC500094981.pdf. Accessed August 5, 2012.

5. FDA. 2010Drug Safety Communication: Ongoing safety review of Actos (pioglitazone) and potential increased risk of bladder cancer after two years exposure. Available from URL http://www.fda.gov/Drugs/Drugsafety/ucm226214.htm. Accessed August 5, 2012.

Cited by 169 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Altered Mental Status in the Solid-Organ Transplant Recipient;Seminars in Neurology;2024-08-24

2. Continuation of Oral Antidiabetic Medications Was Associated With Better Early Postoperative Blood Glucose Control Compared to Sliding Scale Insulin After Total Knee Arthroplasty;The Journal of Arthroplasty;2024-08

3. Continuing Home Oral Hypoglycemic Medications Was Associated With Superior Postoperative Glycemic Control Versus Initiating Sliding Scale Insulin After Total Hip Arthroplasty;Orthopedics;2024-06-27

4. The role of nanosystems in the delivery of glucose-lowering drugs for the preemption and treatment of diabetes-associated atherosclerosis;American Journal of Physiology-Cell Physiology;2024-05-01

5. Residual risk of cardiovascular complications in statin-using patients with type 2 diabetes: the Taiwan Diabetes Registry Study;Lipids in Health and Disease;2024-01-23